My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2024/2390 of 6 September 2024 renewing the approval of the active substance metrafenone in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011

Commission Implementing Regulation (EU) 2024/2390 of 6 September 2024 renewing the approval of the active substance metrafenone in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011

Implementing Regulation (EU) 2024/2390 · Regulation · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Renewal of the approval of the active substance

Article 1

Open ↗

The approval of the active substance metrafenone, as specified in Annex I to this Regulation, is renewed, subject to the conditions laid down in that Annex.

Amendments to Implementing Regulation (EU) No 540/2011

Article 2

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.

Entry into force and date of application

Article 3

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 1 November 2024.

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I Common Name, Identification Numbers IUPAC Name Purity  ( 1 ) Date of approval Expiration of approval Specific provisions Metrafenone CAS No: 220899-03-6 CIPAC No: 752 3′-bromo-2,3,4,6′-tetramethoxy-2′,6-dimethylbenzophenone ≥ 980 g/kg The impurity dimethyl sulphate shall not exceed 0,01 g/kg in the technical material. 1 November 2024 31 October 2039 For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on metrafenone, and in particular Appendices I and II thereto, shall be taken into account. In this overall assessment Member States shall pay particular attention to: — the protection of operators and workers; — the consumer exposure assessment with regards to residues that may be present in food. Conditions of use shall include risk mitigation measures, where appropriate. 1) An updated assessment for point 3.8.2 of Annex II to Regulation (EC) No 1107/2009 to confirm the absence of endocrine activity concerning the T-modality of non-target organisms other than mammals, including where relevant, further information. 2) An updated assessment of the genotoxicity of the metabolites CL 1500834 and CL 3000402. The applicant shall submit the information related to point 1 by 29 March 2026 and the information related to point 2 by 29 December 2024. ( 1 )   Further details on the identity and specification of the active substance are provided in the renewal report.

ANNEX IISupplementary provisions

Open ↗

ANNEX II The Annex to Commission Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in Part A, entry 137 on metrafenone is deleted; (2) in Part B, the following entry is added: No Common Name, Identification Numbers IUPAC Name Purity  ( 1 ) Date of approval Expiration of approval Specific provisions ‘171 Metrafenone CAS No: 220899-03-6 CIPAC No: 752 3′-bromo-2,3,4,6′-tetramethoxy-2′,6-dimethylbenzophenone ≥ 980 g/kg The impurity dimethyl sulphate shall not exceed 0,01 g/kg in the technical material. 1 November 2024 31 October 2039 For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on metrafenone, and in particular Appendices I and II thereto, shall be taken into account. In this overall assessment Member States shall pay particular attention to: — the protection of operators and workers; — the consumer exposure assessment with regards to residues that may be present in food. Conditions of use shall include risk mitigation measures, where appropriate. 1) An updated assessment for point 3.8.2 of Annex II to Regulation (EC) No 1107/2009 to confirm the absence of endocrine activity concerning the T-modality of non-target organisms other than mammals, including where relevant, further information. 2) An updated assessment of the genotoxicity of the metabolites CL 1500834 and CL 3000402. The applicant shall submit the information related to point 1 by 29 March 2026 and the information related to point 2 by 29 December 2024.’ ( 1 )   Further details on the identity and specification of the active substance are provided in the renewal report.

Other acts of the same type
Commission Implementing Regulation (EU) 2016/986 of 13 June 2016 entering a name in the register of protected designations of origin and protected geographical indications (Γλυκό Τριαντάφυλλο Αγρού (Glyko Triantafyllo Agrou) (PGI))Commission Delegated Regulation (EU) 2017/577 of 13 June 2016 supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council on markets in financial instruments with regard to regulatory technical standards on the volume cap mechanism and the provision of information for the purposes of transparency and other calculations (Text with EEA relevance. )Commission Delegated Regulation (EU) 2017/578 of 13 June 2016 supplementing Directive 2014/65/EU of the European Parliament and of the Council on markets in financial instruments with regard to regulatory technical standards specifying the requirements on market making agreements and schemes (Text with EEA relevance. )Commission Delegated Regulation (EU) 2017/579 of 13 June 2016 supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council on markets in financial instruments with regard to regulatory technical standards on the direct, substantial and foreseeable effect of derivative contracts within the Union and the prevention of the evasion of rules and obligations (Text with EEA relevance. )Commission Delegated Regulation (EU) 2016/921 of 10 June 2016 laying down further temporary exceptional support measures for producers of certain fruit and vegetablesCommission Delegated Regulation (EU) 2016/1178 of 10 June 2016 supplementing Regulation (EU) No 648/2012 of the European Parliament and of the Council with regard to regulatory technical standards on the clearing obligation (Text with EEA relevance)Commission Implementing Regulation (EU) 2016/911 of 9 June 2016 laying down implementing technical standards with regard to the form and the content of the description of group financial support agreements in accordance with Directive 2014/59/EU of the European Parliament and of the Council establishing a framework for the recovery and resolution of credit institutions and investment firms (Text with EEA relevance)Commission Regulation (EU) 2016/912 of 9 June 2016 correcting Regulation (EU) No 1303/2014 concerning the technical specification for interoperability relating to ‘safety in railway tunnels’ of the rail system of the European Union (Text with EEA relevance)Commission Delegated Regulation (EU) 2016/1387 of 9 June 2016 amending Annexes I and III to Council Regulation (EC) No 2173/2005 following a Voluntary Partnership Agreement with Indonesia for a FLEGT licensing scheme for imports of timber into the European UnionCommission Implementing Regulation (EU) 2016/895 of 8 June 2016 amending Regulation (EC) No 1290/2008 as regards the name of the holder of the authorisation of a preparation of Lactobacillus rhamnosus (CNCM-I-3698) and Lactobacillus farciminis (CNCM-I-3699) (Text with EEA relevance)Commission Implementing Regulation (EU) 2016/896 of 8 June 2016 concerning the authorisation of iron sodium tartrates as a feed additive for all animal species (Text with EEA relevance)Commission Implementing Regulation (EU) 2016/897 of 8 June 2016 concerning the authorisation of a preparation of Bacillus subtilis (C-3102) (DSM 15544) as a feed additive for laying hens and ornamental fish (holder of authorisation Asahi Calpis Wellness Co. Ltd) and amending Regulations (EC) No 1444/2006, (EU) No 333/2010 and (EU) No 184/2011 as regards the holder of the authorisation (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next